Inve Learning Series
Margin of Safety: Don't Overpay, Even for a Gem
A great business at a terrible price can pay you nothing for years. Graham's margin of safety, the P/E in one line, and a real HUL example for Indian investors.
Inve Content Team · 22 June 2026
A cousin of mine bought a flat in 2014, at the very top of his city's boom. Lovely flat — good builder, right locality, the kind of place you're proud to show people. Ten years on, it's still a lovely flat. And it's worth roughly what he paid for it. The building was never the problem. The price he paid was. He bought a wonderful house at a terrible price, and the price quietly ate a decade of his money while the house just sat there being nice.
Stocks do exactly this, and almost nobody warns the first-time investor about it. You hear "buy great companies." True. You rarely hear the other half: a great company bought at a crazy price can pay you nothing for years. The business keeps doing fine. Your money doesn't. Same trap as the flat.
The price is not the value
Here is the idea that fixes this, and it's almost a hundred years old. Benjamin Graham — the man who taught Warren Buffett — called it the margin of safety, and he made it the final chapter of his book The Intelligent Investor for a reason. He called it "the central concept of investment" and "the secret of sound investment" (Benjamin Graham, The Intelligent Investor, ch. 20, "'Margin of Safety' as the Central Concept of Investment"; the chapter's summary is here).
The rule is plain. A business is worth something — call it its value. The share has a price, and price and value are not the same thing. The margin of safety is the gap between the two: how far below a conservative estimate of value you managed to buy. Buy with a wide gap, and you're protected when you turn out to be wrong, because you will be — about the future, about growth, about how the next three years go. Graham's own words: the function of the margin of safety "is, in essence, that of rendering unnecessary an accurate estimate of the future" (Graham, The Intelligent Investor, ch. 20).
Pay full value, or worse, pay for a future that has to go perfectly, and you've left yourself no room to be wrong. The flat with no margin of safety isn't a bad flat. It's a fine flat with no cushion. The market took the cushion as the price of admission.
How to tell if you're overpaying: the P/E, in one line
You need one simple gauge, and you already half-know it. The price-to-earnings ratio (P/E) is just the price of one share divided by the profit that share earns in a year. A P/E of 25 means you're paying ₹25 for every ₹1 of annual profit. Pay a P/E of 70, and you're handing over ₹70 today for ₹1 of profit — betting that profit grows fast enough, for long enough, to make ₹70 look cheap later.
It is not a verdict on its own. A genuinely fast-growing business can deserve a high P/E. But it is the cleanest first question an owner asks: what am I paying for each rupee this business earns, and does that price already assume a miracle? Pay a miracle price, and even a fine business leaves you waiting.
A real one: a gem that paid zero for three years
Watch it happen with a business no Indian needs introduced — Hindustan Unilever, the company behind Surf Excel, Dove, Lux, Lifebuoy and half the things under your kitchen sink. Nobody disputes it's a quality business. That's exactly why it's the right example: the business was never the problem.
Through these years HUL kept earning, steadily. In FY23 it did about ₹60,580 crore of sales and ₹10,143 crore of net profit; by FY25, ₹62,379 crore of sales and ₹10,671 crore of profit — operating margins parked comfortably around 23–24% the whole way (Inve data, 2026). A calm, profitable, growing machine. No crisis. No scandal. Maggi-steady.
Now the price. HUL touched a peak near ₹2,800 in September 2021 (Inve data, 2026). By the close of 2024 it sat around ₹2,327 (Inve data, 2026). The path between wasn't a clean slide — the stock even printed an all-time high near ₹3,029 in September 2024 before falling back. But that doesn't rescue the person who matters here: someone who bought near the 2021 peak. Read their experience slowly. The business grew its profit through these years, yet more than three years after they paid up, their money was worth less than when they started — they sat through a fresh all-time high and still ended below their entry. The company did its job. The entry price did the damage.
What happened is the whole lesson. Around 2021 the stock carried a very rich P/E — roughly 66 times earnings for the year (companiesmarketcap.com — HUL P/E history), meaning the buyer was paying about ₹66 for every ₹1 of annual profit. That price already baked in years of flawless growth. So when the growth came in merely good instead of spectacular, there was no miracle left to pay for. The P/E shrank back toward earth (analysts call this a "de-rating"), and that shrinking multiple swallowed every rupee the business earned. Wonderful house. Terrible price. A decade-of-the-flat outcome, compressed into a few years.
To be clear, this is not a call on HUL today, up or down — only a finished, visible example of how a great business and a bad return live happily side by side when you overpay.
Test yourself
1/3. What is the 'margin of safety'?
2/3. A share trades at a P/E of 70. What are you paying?
3/3. HUL's business grew its profit while its share price went nowhere for three years. Why?
The froth right next door
If a blue-chip can punish you for overpaying, imagine the small end of the market on a hot day. India just lived through one. In the 2021–24 bull run, money poured into SME IPOs — tiny companies listing on the dedicated small-business segment — at valuations that stopped making sense.
The regulator said so out loud. In August 2024, SEBI issued a formal advisory warning that some SME-listed companies were "projecting an unrealistic picture of their operations," pumping sentiment with announcements and then letting promoters "off-load their holdings… at elevated prices" (SEBI advisory, 28 Aug 2024). The froth had a face: a ₹12-crore IPO by an eight-person automobile dealer drew bids worth around ₹4,800 crore — roughly 400 times the issue size, which translates to the headline "500 times" subscription on the offered shares (Business Today, Aug 2024). The NSE's own chief publicly backed SEBI's concern over inflated SME listings (Business Today, Sep 2024).
Notice what Graham warned in the same chapter, eighty years prior: "the chief losses to investors come from the purchase of low-quality securities at times of favorable business conditions" — people mistake good times for safety and pay up. The 2024 SME mania was that sentence, live, with crores of first-timers in it.
What an owner actually does about it
So how do you avoid your cousin's flat? Not with a magic formula — Graham didn't sell one, and neither will I. With a habit.
Before you buy, separate two questions you're tempted to answer as one: is this a good business? and is this a good price? Both must be yes. A great business at a silly price is a no. The first question is about the company — does it sell more each year, earn real profit (on capital it actually employs), run by people who do what they said? The second is about the price tag — what P/E am I paying, and does it already assume everything goes right?
That second question has another half people forget: management usually tells you what "right" is supposed to look like, on the earnings call. HUL's leadership guided for "double-digit EPS growth in the medium to long term" back in Q3 FY25 — the kind of line a rich valuation leans on. It has since gone quiet on that one (Inve data, 2026). When the growth a high price assumed is the same growth management later stops repeating, that gap is your warning. Reading whether a company is still on track for what it guided — across a whole portfolio, quarter after quarter — is hard to do by hand, which is the job a tool like Inve's Promise Tracker exists to do.
The number you pay is the one variable you fully control. You can't make a business grow faster. You can absolutely refuse to overpay for the version where it does.
See it on a live earnings call
Browse AI-analysed concall summaries — guidance tables, graded Q&A, and the quotes behind them — for 1,500+ listed Indian companies.
Browse concall summariesFrequently asked questions
Inve is a research and analysis platform, not an investment adviser. Nothing here is a recommendation to buy or sell any security. Do your own research or consult a SEBI-registered adviser before investing.